Executive Summary: Clinical Practice Guidelines on the Management of Resistant Tuberculosis of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

• Adrian Sanchez Montalva ^[1] ; José Antonio Caminero ^[2] ; Mª Remedio Guna ^[3] ; Teresa Rodrígo Sanz ^[4] ; Ramón Rabuñal ^[5] ; Joan Pau Millet ^[6] ; José Antonio Gullón Blanco ^[7] ; Luis Anibarro ^[8] ; Guillermo Perez Mendoza ^[9] ; Juan Francisco Medina ^[10] ; Verónica González Galán ^[11] ; Eva Tabernero ^[12]
  1. [1] Universitat Autònoma de Barcelona

     Universitat Autònoma de Barcelona

     Barcelona, España

     
  2. [2] Prof. Head of the Pulmonology Service at the Dr. Negrín General University Hospital, Las Palmas de GC, Spain
  3. [3] Microbiology Service, General University Hospital Consortium of Valencia, Valencia, Spain
  4. [4] Integrated Research Program in Tuberculosis and Non-Tuberculous Mycobacteria (PII-TB&MNT), Centre for Biomedical Research in Public Health Network (CIBERESP), Barcelona Tuberculosis Research Unit, Spain
  5. [5] Infectious Diseases Unit, Internal Medicine Department, Lucus Augusti University Hospital, Lugo, Spain
  6. [6] Epidemiology Service, Public Health Agency of Barcelona, Barcelona, Spain
  7. [7] Pulmonology Section, San Agustín University Hospital, Avilés, Spain
  8. [8] Tuberculosis Unit, Infectious Diseases, Internal Medicine Service, University Hospital Complex, Pontevedra, Spain
  9. [9] Pulmonology Department, Dr. Negrín University Hospital of Gran Canaria, Las Palmas de GC, Spain
  10. [10] Medical-Surgical Unit of Respiratory Diseases (UMQER) Virgen del Rocío University Hospital, Seville, Spain
  11. [11] Clinical Unit of Infectious Diseases, Microbiology, and Clinical Parasitology (UCEIMP), Virgen del Rocío University Hospital, Seville, Spain
  12. [12] Pulmonology Service, Cruces University Hospital (OSI EEC), Barakaldo, Spain

  Mostrar afiliaciones +
• Localización: Archivos de bronconeumología: Organo oficial de la Sociedad Española de Neumología y Cirugía Torácica SEPAR y la Asociación Latinoamericana de Tórax ( ALAT ), ISSN 0300-2896, Vol. 60, Nº. 12, 2024, págs. 759-767
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The Spanish Society of Pneumology and Thoracic Surgery (SEPAR) and the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) have developed together Clinical Practice Guidelines (GPC) on the management of people affected by tuberculosis (TB) resistant to drugs with activity against Mycobacterium tuberculosis. These clinical practice guidelines include the latest updates of the SEPAR regulations for the diagnosis and treatment of drug-resistant TB from 2017 and 2020 as the starting point. The methodology included asking relevant clinical questions based on PICO methodology, a literature search focusing on each question, and a systematic and comprehensive evaluation of the evidence, with a summary of this evidence for each question. Finally, recommendations were developed and the level of evidence and the strength of each recommendation for each question were established in concordance with the GRADE approach. Of the recommendations made, it is worth highlighting the high quality of the existing evidence for the use of nucleic acid amplification techniques (rapid genotypic tests) as initial tests for the detection of the M. tuberculosis genome and rifampicin resistance in people with presumptive signs or symptoms of pulmonary TB; and for the use of an oral combination of anti-TB drugs based on bedaquiline, delamanid (pretomanid), and linezolid, with conditional fluoroquinolone supplementation (conditioned by fluoroquinolone resistance) for six months for the treatment of people affected by pulmonary multidrug-resistant tuberculosis (MDR-TB). We also recommend directly observed therapy (DOT) or video-observed treatment for the treatment of people affected by DR-TB.